MannKind Corporation Reports Third Quarter Financi...(l forward-looking statements are qualifi...),Health

(Tables to follow)

MANNKIND CORPORATION

(A Development Stage Company)

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands except per share data)

Cumulative period

from February 14,

1991 (date of

Three months ended Nine months ended inception) to

September 30, September 30, September 30,

2008 2007 2008 2007 2008

Revenue $- $- $20 $10 $2,988

Operating

expenses:

Research and

development 55,645 64,825 181,665 190,093 928,705

General and

administrative 13,435 10,744 42,365 38,207 232,864

In-process

research and

development costs - - - - 19,726

Goodwill

impairment - - - - 151,428

Total operating

expenses 69,080 75,569 224,030 228,300 1,332,723

Loss from

operations (69,080) (75,569) (224,010) (228,290) (1,329,735)

Other income

(expense) (7) 62 (7) 158 (1,888)

Interest expense

on note

payable to

principal

stockholder - - -
'/>"/>